News
Navigating the Maze: A Proactive Strategy for Wholesaler State Licensing and Regulatory Compliance
Managing licenses for a pharmaceutical or medical device wholesaler is never simple. Every state has its own rules, timelines, interpretations, and expectations. Even experienced compliance teams can miss requirements that lead to delays, fines, or disruptions in...
How Misaligned Licensing Between Manufacturers and 3PLs Create Serious Liability
The pharmaceutical supply chain has become more complex than ever. Manufacturers, virtual manufacturers, CMOs, and CDMOs rely heavily on third party logistics providers to manage distribution, storage, and transportation of finished goods. This networked model...
The Hidden Risks of Using AI for Pharmaceutical License Renewals
Artificial intelligence is transforming the way the pharmaceutical industry operates, from drug discovery to supply chain management. As companies look to automate more administrative tasks, many are beginning to apply AI to license management and renewals. While...
How Supply Chain Complexity is Reshaping Compliance Risk in Pharma
The pharmaceutical supply chain has never been more fragmented than it is today. Manufacturers rely heavily on contract partners with repackagers, relabelers, 3PLs, virtual manufacturers, and own label warehouses now deeply embedded into operational models....
The Final Countdown: What Dispensers Need to Know About the November 27, 2025 DSCSA Deadline
The Drug Supply Chain Security Act (DSCSA) has been a decade in the making, transforming the way prescription drugs are secured, tracked, and verified across the United States. After years of phased requirements, stabilization periods, and exemptions, the...
Pharmaceutical License Renewals Now Open for Key States: Don’t Wait to Get Started
October brings an important milestone for the pharmaceutical industry as several key states have officially opened their license renewal periods. As of October 1st, renewals are now open for Alabama, Louisiana, and New Mexico, with all current licenses set to...
Why CMOs and CDMOs Must Prioritize Emerging State Licensing Requirements: A Strategic Imperative
For Contract Manufacturing Organizations (CMOs) and Contract Drug Manufacturing Organizations (CDMOs), the regulatory currents are shifting in ways that directly impact your strategic value and ability to serve sponsors. A growing, and largely under-appreciated, trend...
Puerto Rico Pharma Compliance: Why a Local Representative Agent is Essential
Puerto Rico is a powerhouse for the life sciences industry, offering a strong foundation for pharmaceutical companies. But as many businesses have learned the hard way, operating on the island isn't as simple as it seems. While the opportunities are vast, the...
Why Hand Verification of Trading Partners Outshines Bulk Data Dumps
In pharmaceutical and life sciences supply chains, trust is everything. Every company depends on the accuracy of its trading partners’ credentials to keep product moving, stay compliant, and avoid regulatory setbacks. Yet many organizations still rely on weekly or...